Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Testing Feasibility of Individualized Therapy for Recurrent Glioblastoma

NCT03681028 is registered in ClinicalTrials.gov with Jennifer Clarke as lead sponsor.

NCT NCT03681028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03681028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Testing Feasibility of Individualized Therapy for Recurrent Glioblastoma
Lead sponsor
Jennifer Clarke
Phase
Phase 1
Overall status
Completed
Start date
December 19, 2018
Completion date
December 31, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma